Education
About Us
Working with TipRanks
Follow Us
Immunocore Holdings (DE:6YG)
FRANKFURT:6YG
Total Valuation
Immunocore Holdings has a market cap or net worth of $1.43B. The enterprise value is €1.89B.
Market Cap$1.43B
Enterprise Value€1.89B
Share Statistics
Immunocore Holdings has 50,233,610 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,233,610
Owned by Insiders4.27%
Owned by Institutions57.49%
Financial Efficiency
Immunocore Holdings’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -8.50%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.05
Return on Invested Capital (ROIC)-8.50%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee629.21K
Profits Per Employee-103.62K
Employee Count493
Asset Turnover0.31
Inventory Turnover0.50
Valuation Ratios
The current PE Ratio of Immunocore Holdings is -28.87. Immunocore Holdings’s PEG ratio is 0.74.
PE Ratio-28.87
PS Ratio0.00
PB Ratio7.74
Price to Fair Value4.09
Price to FCF-64.45
Price to Operating Cash Flow-68.98
PEG Ratio0.74
Income Statement
In the last 12 months, Immunocore Holdings had revenue of 310.20M and earned -51.09M in profits. Earnings per share was -1.02.
Revenue310.20M
Gross Profit307.47M
Operating Income-70.46M
Pretax Income-52.94M
Net Income-51.09M
EBITDA-70.46M
Earnings Per Share (EPS)-1.02
Cash Flow
In the last 12 months, operating cash flow was 31.08M and capital expenditures -5.04M, giving a free cash flow of 26.04M billion.
Operating Cash Flow31.08M
Free Cash Flow26.04M
Free Cash Flow per Share0.52
Dividends & Yields
Immunocore Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change-15.66%
50-Day Moving Average27.26
200-Day Moving Average28.43
Relative Strength Index (RSI)42.60
Average Volume (3m)54.00
Important Dates
Immunocore Holdings upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.
Last Earnings DateMay 7, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Immunocore Holdings as a current ratio of 4.38, with Debt / Equity ratio of 24.86%
Current Ratio4.38
Quick Ratio4.36
Debt to Market Cap0.27
Net Debt to EBITDA0.33
Interest Coverage Ratio-3.74
Taxes
In the past 12 months, Immunocore Holdings has paid -1.85M in taxes.
Income Tax-1.85M
Effective Tax Rate0.03
Enterprise Valuation
Immunocore Holdings EV to EBITDA ratio is -20.60, with an EV/FCF ratio of 69.50.
EV to Sales4.68
EV to EBITDA-20.60
EV to Free Cash Flow69.50
EV to Operating Cash Flow55.70
Balance Sheet
Immunocore Holdings has $837.03M in cash and marketable securities with $42.47M in debt, giving a net cash position of -$794.57M billion.
Cash & Marketable Securities$837.03M
Total Debt$42.47M
Net Cash-$794.57M
Net Cash Per Share-$15.82
Tangible Book Value Per Share$7.22
Margins
Gross margin is 99.68%, with operating margin of -22.71%, and net profit margin of -16.47%.
Gross Margin99.68%
Operating Margin-22.71%
Pretax Margin-17.07%
Net Profit Margin-16.47%
EBITDA Margin-22.71%
EBIT Margin-23.14%
Analyst Forecast
The average price target for Immunocore Holdings is $56.27, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$56.27
Price Target Upside100.95% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast―
EPS Growth Forecast―